Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/78132
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Using living cells to transport therapeutic genes for cancer treatment

AuthorsLatorre-Romero, Camino; Belmar-Lopez, Carolina; Quintanilla, Miguel CSIC ORCID; Martín-Duque, Pilar
Issue Date2011
PublisherSpringer
CitationClinical and Translational Oncology 13(1): 10-17 (2011)
AbstractOne of the key problems in cancer gene therapy is the inefficient delivery of therapeutic transgenes to tumour sites, after the systemic injection of the viral vector. Hence, new vector discovery is extremely important for the improvement of gene therapy results. Previously, mammalian cells were proposed as new vector systems; however with recent advances in stem cell research this modality makes them more suitable candidates. Tumours are composed of both malignant and benign cells. As >benign> cell types are able to form blood vessels, and stroma, it has been hypothesised that exogenously administrated cells of a different kind would preferentially engraft at the stromal tumour site and could deliver cancer gene therapy vectors to tumours.
URIhttp://hdl.handle.net/10261/78132
DOI10.1007/s12094-011-0611-3
Identifiersdoi: 10.1007/s12094-011-0611-3
issn: 1699-048X
e-issn: 1699-3055
Appears in Collections:(IIBM) Artículos




Files in This Item:
File Description SizeFormat
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

SCOPUSTM   
Citations

5
checked on May 22, 2022

WEB OF SCIENCETM
Citations

5
checked on May 20, 2022

Page view(s)

291
checked on May 26, 2022

Download(s)

84
checked on May 26, 2022

Google ScholarTM

Check

Altmetric

Dimensions


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.